NEW YORK (MedscapeWire) Dec 27 — Mayo Clinic researchers report the successful use of an antiretroviral drug to combat a brain disease that is responsible for death in as many as 5% of patients with ...

Discerning the number of individual factors that may contribute collectively to liver damage is difficult in patients receiving antiretroviral therapy. Several drugs are combined in a given HAART ...

Recent developments in the pharmacogenomics of antiretroviral drugs provide new prospects for predicting the efficacy of treatment and potential adverse effects. HIV/AIDS is a serious but treatable ...

Indication: HIV-1 infection in antiretroviral treatment-naïve adult patients, in combination with other antiretroviral agents. Pharmacology: Rilpivirine is a diarylpyrimidine NNRTI of HIV-1 and ...

Nucleoside reverse transcriptase translocation inhibitors (NRTTIs) are a novel class of antiretroviral agents that inhibit HIV replication by targeting the viral reverse transcriptase enzyme and ...